Tharimmune, Inc. Files 8-K: Director Changes and Officer Compensation
Ticker: CNTN · Form: 8-K · Filed: Oct 9, 2025 · CIK: 1861657
| Field | Detail |
|---|---|
| Company | Tharimmune, INC. (CNTN) |
| Form Type | 8-K |
| Filed Date | Oct 9, 2025 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: director-change, officer-compensation, corporate-governance
TL;DR
Tharimmune's board is changing: Hunt out, Epstein in. Officer pay details also filed.
AI Summary
On October 9, 2025, Tharimmune, Inc. filed an 8-K report detailing several key events. The company announced the departure of Director Dr. Jonathan T. Hunt and the appointment of Dr. David M. Epstein as a new director. Additionally, the filing includes information on compensatory arrangements for certain officers and submissions of matters to a vote of security holders.
Why It Matters
Changes in board composition and executive compensation can signal shifts in company strategy or governance, impacting investor confidence and future performance.
Risk Assessment
Risk Level: medium — Director departures and changes in compensatory arrangements can indicate internal shifts or strategic realignments that may carry inherent risks.
Key Players & Entities
- Tharimmune, Inc. (company) — Registrant
- Dr. Jonathan T. Hunt (person) — Departing Director
- Dr. David M. Epstein (person) — Appointed Director
- October 9, 2025 (date) — Filing Date
FAQ
Who has departed from Tharimmune, Inc.'s board of directors?
Dr. Jonathan T. Hunt has departed from the board of directors.
Who has been appointed as a new director to Tharimmune, Inc.'s board?
Dr. David M. Epstein has been appointed as a new director.
What is the exact filing date of this 8-K report?
The filing date of this 8-K report is October 9, 2025.
What other items are covered in this 8-K filing besides director changes?
This filing also covers compensatory arrangements of certain officers and the submission of matters to a vote of security holders.
What is the state of incorporation for Tharimmune, Inc.?
Tharimmune, Inc. is incorporated in Delaware.
Filing Stats: 876 words · 4 min read · ~3 pages · Grade level 12.4 · Accepted 2025-10-09 16:15:17
Key Financial Figures
- $0.0001 — nge on which registered Common stock, $0.0001 par value THAR The Nasdaq Stock Mar
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex10-1.htm (EX-10.1) — 11KB
- 0001493152-25-017596.txt ( ) — 226KB
- thar-20251009.xsd (EX-101.SCH) — 3KB
- thar-20251009_lab.xml (EX-101.LAB) — 33KB
- thar-20251009_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 9, 2025 THARIMMUNE, INC. /s/ Sireesh Appajosyula Sireesh Appajosyula Chief Executive Officer -3-